[Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer]Yang Yao
Department of Medical Oncology, The Sixth People s Hospital, Shanghai Jiaotong University, Shanghai, 200233, P R China
Ai Zheng 25:1035-8. 2006
..This study was to evaluate the short-term effects and toxicity of combination of hydroxycamptothecine (HCPT) plus oxaliplatin (L-OHP) protocol in the treatment of recurrent and metastatic colorectal cancer...
- Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
Yang Yao
Department of Oncology, Shanghai Sixth People's Hospital of Shanghai JiaoTong University, Shanghai 200233, China
Chin Med J (Engl) 119:1829-33. 2006
- [Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers]
Yuan-jue Sun
Department of Medical Oncology, Sixth People's Hospital, Shanghai University of Commanications, Shanghai 200233, China
Zhonghua Zhong Liu Za Zhi 26:749-52. 2004
..CONCLUSION: Satisfactory response rate is obtainable in advanced colorectal cancer as treated by hydroxycamptothecine plus oxaliplatin. The toxicity consists of severe leukocytopenia and diarrhea...
Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcomaFeng Lin
Department of Oncology, Affiliated 6th People s Hospital, Shanghai Jiao Tong University, Shanghai, People s Republic of China
Med Oncol 28:649-53. 2011
..03) or VEGF (P = 0.04). These data indicate that CXCR4 and VEGF expression is highly correlated with metastatic progression in patients with osteosarcoma and had predictive value for the metastasis and survival of osteosarcoma patients...
- The expression of CRM1 is associated with prognosis in human osteosarcoma
Yang Yao
Department of Oncology, Affiliated 6th People s Hospital, Shanghai Jiaotong University, Shanghai 200223, P R China
Oncol Rep 21:229-35. 2009
..27-5.39). Additional prospective studies are required to investigate the prognostic role of high expression of CRM1...
- Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients
Wei Xiang Qi
Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
Jpn J Clin Oncol 42:427-31. 2012
..In this study, we describe experiences with gemcitabine-docetaxel combination therapy as salvage treatment for Chinese patients with recurrent or refractory high-grade osteosarcoma...
- Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison
Wei Xiang Qi
Department of Oncology, Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
Curr Med Res Opin 28:643-50. 2012
..This paper aims to systematically review the evidence from all available clinical trials of erlotinib and pemetrexed as maintenance therapy for advanced NSCLC...
- Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis
Wei Xiang Qi
Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, China
J Cancer Res Clin Oncol 138:745-51. 2012
..To compared pemetrexed-based doublet with single-agent pemetrexed as second-line treatment for advanced non-small-cell lung cancer..
- Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer
Yang Yao
Department of Medical Oncology, Sixth People s Hospital, Shanghai Jiaotong University, China
Tohoku J Exp Med 215:267-78. 2008
..Taken together, the present study indicates that the combined chemotherapy of HCPT with L-OHP could become a new adjuvant treatment for CRC...
- Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials
Wei Xiang Qi
Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
Curr Med Res Opin 29:117-25. 2013
..We therefore performed a meta-analysis of randomized controlled trials to compare the safety and efficacy of these two regimens in MBC...
- Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: an updated meta-analysis of ten randomized controlled trials
Wei Xiang Qi
Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
Int J Cancer 132:E66-73. 2013
..A clear advantage of irinotecan-containing over nonirinotecan-containing regimen had not been established. These results should help to inform decisions about patient management and design of future trials...
- Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis
Wei Xiang Qi
Department of Oncology, Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, China
Asian Pac J Cancer Prev 13:5177-82. 2012
....
- Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer
Wei Xiang Qi
Department of Oncology, The Sixth People Hospital, Medical College of Shanghai Jiao Tong University, Shanghai 200233, China
Cancer Chemother Pharmacol 69:99-106. 2012
..To compare docetaxel-based doublet with single-agent docetaxel as second-line treatment in non-small-cell lung cancer (NSCLC)...
- Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest
Shui Er Zheng
Department of Oncology, Affiliated People s 6th Hospital, Shanghai Jiao Tong University, China
Acta Pharmacol Sin 33:832-8. 2012
..In this study, the effects of THP on the multidrug-resistant (MDR) osteosarcoma cells were assessed, and the underlying mechanisms for the disruption of cell cycle kinetics by THP were explored...
- Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide
Feng Lin
No 6 People s Hospital of Shanghai Jiaotong University, Shanghai, China
Asia Pac J Clin Oncol 7:270-5. 2011
..The objective of this study was to investigate the efficacy and toxic side effects of two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide on treating Chinese osteosarcoma patients...
- Primary splenic angiosarcoma
Zengjun Liu
Shanghai No 6 Hospital, Shanghai, China
Vasa 41:57-62. 2012
..The outcome of this disease is typically dismal with a mean survival of one to two years. However, our here presented case remained uncommonly symptom-free for nine years after splenectomy alone at the early phase of the disease...
- Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis
Wei Xiang Qi
Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, No 600, Yishan Road, Shanghai, 200233, China
Lung 190:477-85. 2012
....
- Variances handling method of clinical pathways based on T-S fuzzy neural networks with novel hybrid learning algorithm
Gang Du
Department of Industrial Engineering and Logistics Management, Shanghai Jiao Tong University, Shanghai, China
J Med Syst 36:1283-300. 2012
....
- The role of vandetanib in the second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of four randomized controlled trials
Wei Xiang Qi
Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
Lung 189:437-43. 2011
..The purpose of this study was to assess the efficacy and toxicity of vandetanib in the second-line treatment for advanced non-small cell lung cancer (NSCLC)...
- Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute
Wei Xiang Qi
Department of Oncology, The Sixth People s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
Med Oncol 29:2229-33. 2012
..THP-DDP regimen chemotherapy represents an active and well-tolerated treatment for Chinese refractory and recurrent high-grade osteosarcoma patients. Further assessment is necessary to confirm the safety and efficacy of this treatment...
- CT fluoroscopy-guided percutaneous osteoplasty for the treatment of osteolytic lung cancer bone metastases to the spine and pelvis
Zhiyu Wang
Department of Internal Oncology, Shanghai Jiaotong University, Shanghai, China
J Vasc Interv Radiol 23:1135-42. 2012
..To retrospectively assess the results of computed tomographic (CT) fluoroscopy-guided percutaneous osteoplasty (PO) of osteolytic lung cancer bone metastases, focusing on pain reduction, improved quality of life, and patient mobility...
- Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors
Hui Zhao
Department of Internal Oncology, Sixth People s Hospital, Shanghai Jiaotong University, Shanghai, China
Med Sci Monit 17:CR626-633. 2011
..The present study aimed to investigate the value of biochemical markers of bone turnover in the diagnosis and prognosis of bone metastases of malignant tumors...
- Down-regulation of ribosomal protein L7A in human osteosarcoma
Shui Er Zheng
Department of Oncology, Affiliated People s 6th Hospital, Shanghai Jiaotong University, 200233 Shanghai, People s Republic of China
J Cancer Res Clin Oncol 135:1025-31. 2009
..To explore the expression of ribosomal protein L7A (RPL7A) in osteosarcoma and its correlation with clinical features...
- Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
Wei Xiang Qi
Department of Oncology, The Sixth People Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China
J Cancer Res Clin Oncol 137:1785-90. 2011
..To assess the efficacy and toxicity of the addition of estramustine to docetaxel-based chemotherapy for the treatment of castration-resistant prostate cancer...
- Knowledge extraction algorithm for variances handling of CP using integrated hybrid genetic double multi-group cooperative PSO and DPSO
Gang Du
Department of Industrial Engineering and Logistics Management, Shanghai Jiao Tong University, Shanghai, China
J Med Syst 36:979-94. 2012
....
